BCIwiki (bciwiki.com) — Johns Hopkins University is conducting an early feasibility study to evaluate the safety and efficacy of the Bidirectional Cortical Neuroprosthetic System (BiCNS), a device first publicly listed on May 19, 2017, and currently recruiting participants.
BiCNS comprises NeuroPort Microelectrode Array Systems, NeuroPort Electrodes (Sputtered Iridium Oxide Film), Patient Pedestals, the NeuroPort BioPotential Signal Processing System, and the CereStim C96 Programmable Stimulator. The trial targets patients with tetraplegia and quadriplegia and is based in the United States. The system combines neural signal recording and neuromodulation, representing an invasive BCI approach.